SAN FRANCISCO-(BUSINESS WIRE)-DiCE Molecules, a biopharmaceutical company leveraging its proprietary DNA-encoded library platform to discover and develop next-generation therapeutics in... Read More The post DiCE Molecules Announces $60 Million Series C-1 appeared first on citybiz.
